190 related articles for article (PubMed ID: 36054930)
21. Enhanced Dendritic Actin Network Formation in Extended Lamellipodia Drives Proliferation in Growth-Challenged Rac1
Mohan AS; Dean KM; Isogai T; Kasitinon SY; Murali VS; Roudot P; Groisman A; Reed DK; Welf ES; Han SJ; Noh J; Danuser G
Dev Cell; 2019 May; 49(3):444-460.e9. PubMed ID: 31063759
[TBL] [Abstract][Full Text] [Related]
22. Cabozantinib Is Effective in Melanoma Brain Metastasis Cell Lines and Affects Key Signaling Pathways.
Mannsåker TA; Hoang T; Aasen SN; Bjørnstad OV; Parajuli H; Sundstrøm T; Thorsen FA
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830178
[TBL] [Abstract][Full Text] [Related]
23. The RPL/RPS gene signature of melanoma CTCs associates with brain metastasis.
Bowley TY; Lagutina IV; Francis C; Sivakumar S; Selwyn RG; Taylor E; Guo Y; Fahy BN; Tawfik B; Marchetti D
Cancer Res Commun; 2022 Nov; 2(11):1436-1448. PubMed ID: 36407834
[TBL] [Abstract][Full Text] [Related]
24. Current and emerging options for patients with melanoma brain metastases.
Kreidieh FY; Tawbi HA
Clin Adv Hematol Oncol; 2022 Oct; 20(10):619-627. PubMed ID: 36206074
[TBL] [Abstract][Full Text] [Related]
25. DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations.
Marzese DM; Scolyer RA; Roqué M; Vargas-Roig LM; Huynh JL; Wilmott JS; Murali R; Buckland ME; Barkhoudarian G; Thompson JF; Morton DL; Kelly DF; Hoon DS
Neuro Oncol; 2014 Nov; 16(11):1499-509. PubMed ID: 24968695
[TBL] [Abstract][Full Text] [Related]
26. The role of systemic therapy in melanoma brain metastases: a narrative review.
Saleem K; Davar D
Chin Clin Oncol; 2022 Jun; 11(3):24. PubMed ID: 35818856
[TBL] [Abstract][Full Text] [Related]
27. Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG.
Franklin C; Mohr P; Bluhm L; Grimmelmann I; Gutzmer R; Meier F; Garzarolli M; Weichenthal M; Pfoehler C; Herbst R; Terheyden P; Utikal J; Ulrich J; Debus D; Haferkamp S; Kaatz M; Forschner A; Leiter U; Nashan D; Kreuter A; Sachse M; Welzel J; Heinzerling L; Meiss F; Weishaupt C; Gambichler T; Weyandt G; Dippel E; Schatton K; Celik E; Trommer M; Helfrich I; Roesch A; Zimmer L; Livingstone E; Schadendorf D; Horn S; Ugurel S
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35688555
[TBL] [Abstract][Full Text] [Related]
28. Melanoma central nervous system metastases: An update to approaches, challenges, and opportunities.
Karz A; Dimitrova M; Kleffman K; Alvarez-Breckenridge C; Atkins MB; Boire A; Bosenberg M; Brastianos P; Cahill DP; Chen Q; Ferguson S; Forsyth P; Glitza Oliva IC; Goldberg SB; Holmen SL; Knisely JPS; Merlino G; Nguyen DX; Pacold ME; Perez-Guijarro E; Smalley KSM; Tawbi HA; Wen PY; Davies MA; Kluger HM; Mehnert JM; Hernando E
Pigment Cell Melanoma Res; 2022 Nov; 35(6):554-572. PubMed ID: 35912544
[TBL] [Abstract][Full Text] [Related]
29. Treatment patterns and outcomes in BRAF V600E-mutant melanoma patients with brain metastases receiving vemurafenib in the real-world setting.
Gibney GT; Gauthier G; Ayas C; Galebach P; Wu EQ; Abhyankar S; Reyes C; Guérin A; Yim YM
Cancer Med; 2015 Aug; 4(8):1205-13. PubMed ID: 25991583
[TBL] [Abstract][Full Text] [Related]
30. Melanoma brain metastases - Interdisciplinary management recommendations 2020.
Gutzmer R; Vordermark D; Hassel JC; Krex D; Wendl C; Schadendorf D; Sickmann T; Rieken S; Pukrop T; Höller C; Eigentler TK; Meier F
Cancer Treat Rev; 2020 Sep; 89():102083. PubMed ID: 32736188
[TBL] [Abstract][Full Text] [Related]
31. Toxicity and efficacy of Gamma Knife radiosurgery for brain metastases in melanoma patients treated with immunotherapy or targeted therapy-A retrospective cohort study.
Gatterbauer B; Hirschmann D; Eberherr N; Untersteiner H; Cho A; Shaltout A; Göbl P; Fitschek F; Dorfer C; Wolfsberger S; Kasprian G; Höller C; Frischer JM
Cancer Med; 2020 Jun; 9(11):4026-4036. PubMed ID: 32249551
[TBL] [Abstract][Full Text] [Related]
32. Pathologic and gene expression features of metastatic melanomas to the brain.
Hamilton R; Krauze M; Romkes M; Omolo B; Konstantinopoulos P; Reinhart T; Harasymczuk M; Wang Y; Lin Y; Ferrone S; Whiteside T; Bortoluzzi S; Werley J; Nukui T; Fallert-Junecko B; Kondziolka D; Ibrahim J; Becker D; Kirkwood J; Moschos S
Cancer; 2013 Aug; 119(15):2737-46. PubMed ID: 23695963
[TBL] [Abstract][Full Text] [Related]
33. Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases.
Jiang C; Kleber TJ; Switchenko JM; Khan MK
Radiat Oncol; 2021 Feb; 16(1):31. PubMed ID: 33557890
[TBL] [Abstract][Full Text] [Related]
34. Matched three-dimensional organoids and two-dimensional cell lines of melanoma brain metastases mirror response to targeted molecular therapy.
Hicks WH; Gattie LC; Traylor JI; Davar D; Najjar YG; Richardson DO TE; McBrayer SK; Abdullah KG
bioRxiv; 2024 Jan; ():. PubMed ID: 38328251
[TBL] [Abstract][Full Text] [Related]
35. Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in China.
Wang Y; Lian B; Si L; Chi Z; Sheng X; Wang X; Mao L; Tang B; Li S; Yan X; Bai X; Zhou L; Cui C; Guo J
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2731-2740. PubMed ID: 33611636
[TBL] [Abstract][Full Text] [Related]
36. Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases.
Hilbers ML; Dimitriou F; Lau P; Bhave P; McArthur GA; Zimmer L; Kudura K; Gérard CL; Levesque MP; Michielin O; Dummer R; Cheng PF; Mangana J
Eur J Cancer; 2021 Oct; 156():149-163. PubMed ID: 34454317
[TBL] [Abstract][Full Text] [Related]
37. Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases.
In GK; Poorman K; Saul M; O'Day S; Farma JM; Olszanski AJ; Gordon MS; Thomas JS; Eisenberg B; Flaherty L; Weise A; Daveluy S; Gibney G; Atkins MB; Vanderwalde A
Oncotarget; 2020 Aug; 11(33):3118-3128. PubMed ID: 32913556
[TBL] [Abstract][Full Text] [Related]
38. Matching wits with melanoma brain metastases: from biology to therapeutics.
Tawbi H
Clin Cancer Res; 2014 Nov; 20(21):5346-8. PubMed ID: 25135484
[TBL] [Abstract][Full Text] [Related]
39. Developments in therapy for brain metastases in melanoma patients.
Wilkes JG; Patel A; McClure E; Pina Y; Zager JS
Expert Opin Pharmacother; 2021 Aug; 22(11):1443-1453. PubMed ID: 33688795
[No Abstract] [Full Text] [Related]
40. Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients.
Amaral T; Kiecker F; Schaefer S; Stege H; Kaehler K; Terheyden P; Gesierich A; Gutzmer R; Haferkamp S; Uttikal J; Berking C; Rafei-Shamsabadi D; Reinhardt L; Meier F; Karoglan A; Posch C; Gambichler T; Pfoehler C; Thoms K; Tietze J; Debus D; Herbst R; Emmert S; Loquai C; Hassel JC; Meiss F; Tueting T; Heinrich V; Eigentler T; Garbe C; Zimmer L;
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32221017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
